Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bonmassar

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood culturesC D'Onofrio, C D Pesce, T Fontana, et al.
Biochemical Pharmacology|July 31, 1995
Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell lineK Lu, M B Yin, J J McGuire, et al.
Leukemia|November 1, 1995
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell linesL Tentori, G Graziani, S Gilberti, et al.
Acta Neurologica|April 1, 1991
HTLV-I neurotropism. In vitro studiesB Macchi, B Caronti, F Gremo, et al.
International Journal of Tissue Reactions|January 1, 1987
Differential susceptibility of human mononuclear cells to infection with HTLV-IB Macchi, M Popovic, P Allavena, et al.
Anticancer Research|December 22, 1998
Effect of 4-hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 target cellsM Rinaldi, M Tricarico, E Bonmassar, et al.
British Journal of Cancer|May 1, 1988
Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferonC D'Onofrio, C F Perno, P Mazzetti, et al.
Journal of the National Cancer Institute|May 1, 1978
Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated miceC Riccardi, M C Fioretti, A Giampietri, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studiesB Nardelli, P Puccetti, L Romani, et al.
Immunopharmacology|May 1, 1991
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cellsS D'Atri, S Marini, L Tentori, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood culturesC D'Onofrio, C D Pesce, T Fontana, et al.
Biochemical Pharmacology|July 31, 1995
Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell lineK Lu, M B Yin, J J McGuire, et al.
Leukemia|November 1, 1995
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell linesL Tentori, G Graziani, S Gilberti, et al.
Acta Neurologica|April 1, 1991
HTLV-I neurotropism. In vitro studiesB Macchi, B Caronti, F Gremo, et al.
International Journal of Tissue Reactions|January 1, 1987
Differential susceptibility of human mononuclear cells to infection with HTLV-IB Macchi, M Popovic, P Allavena, et al.
Anticancer Research|December 22, 1998
Effect of 4-hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 target cellsM Rinaldi, M Tricarico, E Bonmassar, et al.
British Journal of Cancer|May 1, 1988
Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferonC D'Onofrio, C F Perno, P Mazzetti, et al.
Journal of the National Cancer Institute|May 1, 1978
Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated miceC Riccardi, M C Fioretti, A Giampietri, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studiesB Nardelli, P Puccetti, L Romani, et al.
Immunopharmacology|May 1, 1991
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cellsS D'Atri, S Marini, L Tentori, et al.
Pageof 19